BLFS Biolife Solutions Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BLFS

Price (delayed)

$24.045

Market cap

$1.11B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.42

Enterprise value

$1.12B

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Its products and services portfolio includes its proprietary CryoStor® freeze media, HypoThermosol® shipping and storage ...

Highlights
The EPS has surged by 59% year-on-year and by 7% since the previous quarter
BLFS's net income has surged by 57% year-on-year and by 5% since the previous quarter
The company's gross profit fell by 19% YoY and by 3.2% QoQ
The company's revenue fell by 16% YoY and by 4.2% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.biolifesolutions.com
Peers: CE ENTA

Key stats

What are the main financial stats of BLFS
Market
Shares outstanding
46.03M
Market cap
$1.11B
Enterprise value
$1.12B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.27
Price to sales (P/S)
7.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.14
Earnings
Revenue
$137.3M
EBIT
-$61.12M
EBITDA
-$49.74M
Free cash flow
-$22.02M
Per share
EPS
-$1.42
Free cash flow per share
-$0.48
Book value per share
$7.36
Revenue per share
$3.02
TBVPS
$3.45
Balance sheet
Total assets
$401.6M
Total liabilities
$68.2M
Debt
$40.96M
Equity
$333.41M
Working capital
$73.04M
Liquidity
Debt to equity
0.12
Current ratio
2.89
Quick ratio
1.65
Net debt/EBITDA
-0.23
Margins
EBITDA margin
-36.2%
Gross margin
33%
Net margin
-45.8%
Operating margin
-51.2%
Efficiency
Return on assets
-15.2%
Return on equity
-18.6%
Return on invested capital
-42.8%
Return on capital employed
-16.8%
Return on sales
-44.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BLFS stock price

How has the Biolife Solutions stock price performed over time
Intraday
4.41%
1 week
14.39%
1 month
11.89%
1 year
23.69%
YTD
47.97%
QTD
12.2%

Financial performance

How have Biolife Solutions's revenue and profit performed over time
Revenue
$137.3M
Gross profit
$45.27M
Operating income
-$70.26M
Net income
-$62.93M
Gross margin
33%
Net margin
-45.8%
BLFS's net income has surged by 57% year-on-year and by 5% since the previous quarter
BLFS's operating income has soared by 54% YoY and by 3.8% QoQ
The net margin has grown by 49% year-on-year
The operating margin has increased by 45% YoY

Growth

What is Biolife Solutions's growth rate over time

Valuation

What is Biolife Solutions stock price valuation
BLFS P/E details
P/E
N/A
P/B
3.27
P/S
7.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.14
The EPS has surged by 59% year-on-year and by 7% since the previous quarter
BLFS's price to book (P/B) is 36% higher than its last 4 quarters average of 2.3 but 11% lower than its 5-year quarterly average of 3.5
The equity has contracted by 7% YoY
The P/S is 47% higher than the last 4 quarters average of 5.2 but 31% lower than the 5-year quarterly average of 11.0
The company's revenue fell by 16% YoY and by 4.2% QoQ

Efficiency

How efficient is Biolife Solutions business performance
The ROIC has soared by 54% YoY
Biolife Solutions's return on assets has surged by 52% YoY and by 2.6% QoQ
The return on sales has surged by 51% year-on-year
The ROE has soared by 51% YoY and by 3.6% from the previous quarter

Dividends

What is BLFS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BLFS.

Financial health

How did Biolife Solutions financials performed over time
The total liabilities has decreased by 23% YoY and by 9% from the previous quarter
The total assets has decreased by 10% YoY and by 2.7% QoQ
The debt is 88% smaller than the equity
Biolife Solutions's debt to equity has decreased by 8% from the previous quarter
The equity has contracted by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.